PLP8 Antibody
Description
Overview of PLP Antibodies
PLP antibodies target proteolipid protein, a critical myelin component in the central nervous system (CNS) and peripheral nervous system (PNS). These antibodies are implicated in autoimmune diseases like multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) .
Key functional domains:
-
Extracellular epitopes: PLP50–69, PLP178–191, and PLP200–219 are major targets for pathogenic antibodies .
-
Cytoplasmic epitopes: PLP264–276 is associated with non-pathogenic IgM responses .
Mechanisms of Action
Anti-PLP antibodies exhibit multispecific binding to neuronal surface proteins, including:
Autoimmune Disorders:
-
MS: Anti-PLP181–230 antibodies correlate with disease severity in HLA-matched patients .
-
NMOSD: PLP1-IgG coexists with AQP4/MOG antibodies in 3.2% of cases and associates with myelitis/encephalomyelitis .
Experimental Models:
Research Limitations
-
No studies validate a "PLP8" epitope or antibody clone.
-
Current nomenclature uses positional numbering (e.g., PLP50–69) or clone IDs (e.g., F4.4C2) .
Recommendations
Product Specs
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Target Background
Q&A
Here’s a structured collection of FAQs tailored for academic research scenarios involving PLP8 antibodies, synthesized from peer-reviewed studies and technical guidelines:
Advanced Research Challenges
How to resolve contradictory data on PLP8’s role in neuronal regeneration?
-
Epitope mapping: Compare antibodies targeting distinct PLP regions (e.g., 50–69 vs. 264–276). F4.4C2 (50–69) inhibits regeneration, while P5.12A8 (264–276) shows no effect .
-
Model selection: Use E18 rat hippocampal precursors for developmental studies and PC12 cells for neurodifferentiation assays .
What strategies mitigate cross-reactivity with non-PLP neuronal surface antigens?
-
Pre-adsorb antibodies against M6 proteins or Eph receptors using affinity columns .
-
Validate via siRNA knockdown of PLP in target cells and assess antibody binding loss .
How does HLA-restricted anti-PLP antibody response impact translational MS research?
-
Screen patient cohorts for HLA-DRB1*15:01 alleles, which correlate with elevated anti-PLP181–230 IgG1/IgG3 and worse EDSS scores (p<0.01) .
-
Use peptide arrays spanning PLP139–151 and MOG35–55 to map epitope spreading in relapsing EAE models .
Technical Optimization
Standardizing PLP8 antibody dilutions across CNS regions in human autopsies
-
Adjust concentrations based on tissue maturity:
Interpreting variable PLP8 signals in Western blots of myelinating oligodendrocytes
-
Sample prep: Include 1% octyl glucoside to solubilize PLP aggregates .
-
Normalization: Use CNPase (2',3'-cyclic nucleotide 3'-phosphodiesterase) as a loading control for myelin-rich fractions .
